Digital Revolution Will Not Be Free: Facilitating OTC Switches, Engaging Consumers
This article was originally published in The Tan Sheet
Digital technologies could transform how consumers shop for OTC drugs in stores, but costs could be significant, say industry consultants. Marketers are looking to create digital “touch points” such as interactive kiosks to create two-way communication between brands and customers.
You may also be interested in...
FDA official Rikin Mehta assures stakeholders that the proposed new paradigm for Rx-to-OTC switches would not create a third class of drugs, give pharmacists prescribing power or eliminate the need for consumers to visit doctors.
Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.
The Personal Care Products Council is pivoting to focus on passing cosmetics modernization legislation after mid-term congressional elections, while still hopeful the language could go through as part of FDA user-fee reauthorization. Karin Ross, executive VP, government affairs at PCPC, discussed the situation at the trade group’s Leadership Summit in Washington.